Trial Profile
An open label study to evaluate the effects on Mycobacterium tuberculosis, safety, tolerability and pharmacokinetics of single doses of R207910, in treatment naive patients with mycobacterium tuberculosis infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2020
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- Sponsors Janssen R&D Ireland
- 27 Jul 2020 Status changed from recruiting to completed.
- 26 Jul 2011 New trial record